Prediction models of persistent taxane-induced peripheral neuropathy among breast cancer survivors using whole-exome sequencingNPJ PRECISION ONCOLOGYIF82024-05-160OAAI
Enhancer mutations modulate the severity of chemotherapy-induced myelosuppressionLIFE SCIENCE ALLIANCEIF2.92024-01-163OAAI
Early changes in gene expression profiles in AML patients during induction chemotherapyBMC GENOMICSIF3.72022-11-143OAAI
Prediction of persistent taxane-induced peripheral neuropathy among early-stage breast cancer survivors using whole-exome sequencingANNALS OF ONCOLOGYIF65.42022-09-010PRE
IFNγ directly counteracts imatinib-induced apoptosis of primary human CD34+CML stem/progenitor cells potentially through the upregulation of multiple key survival factorsONCOIMMUNOLOGYIF6.32022-08-123OA
Combination of tyrosine kinase inhibitors and the MCL1 inhibitor S63845 exerts synergistic antitumorigenic effects on CML cellsCELL DEATH & DISEASEIF9.62021-09-259OAAI
Whole-genome sequencing and gene network modules predict gemcitabine/carboplatin-induced myelosuppression in non-small cell lung cancer patientsNPJ SYSTEMS BIOLOGY AND APPLICATIONSIF3.52020-08-2410OAAI
Association to drug-induced leukopenia using whole-exome sequencing of non-small cell lung cancer patients on gemcitabine/carboplatin regimenCANCER RESEARCHIF16.62017-07-011PRE
Whole exome sequencing and genetic association of gemcitabine/carboplatin induced thrombocytopenia in non-small cell lung cancer patientsCANCER RESEARCHIF16.62017-07-010PRE
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向